Clinical Trials Logo

Clinical Trial Summary

To measure the level of serum elafin in patients with behcet disease and to assess the correlation between serum elafin and vascular affection and their relation with disease activity


Clinical Trial Description

Behcet disease is a chronic multi systemic inflammatory disease characterized by recurrent oral and genital ulcers and multiple systemic affection . Elafin is a serine protease inhibitor produced mainly by epithelial cells . previous studies documented the role of serum elafin in pathogenesis of behcet disease.vascular complications may be one if the earliest manifestation leading to the diagnosis of behcet disease. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06280430
Study type Observational
Source Assiut University
Contact
Status Not yet recruiting
Phase
Start date March 1, 2024
Completion date April 1, 2025